Westpac Banking Corp’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,624	Closed	-$348K	–	902
2017 Q1	$348K	Sell	7,624 -14	-0.2%	-$605	﹤0.01%	870
2016 Q4	$247K	Buy	7,638 +70	+0.9%	+$2.34K	﹤0.01%	805
2016 Q3	$259K	Buy	7,568 +1,691	+29%	+$66.3K	﹤0.01%	770
2016 Q2	$198K	Buy	5,877 +1,870	+47%	+$91.9K	﹤0.01%	843
2016 Q1	$212K	Buy	4,007 +153	+4%	+$8.95K	﹤0.01%	795
2015 Q4	$296K	Buy	3,854 +151	+4%	+$8.55K	﹤0.01%	774
2015 Q3	$152K	Buy	3,703 +1,417	+62%	+$86.8K	﹤0.01%	814
2015 Q2	$162K	Buy	2,286 +31	+1%	+$2.44K	﹤0.01%	683
2015 Q1	$200K	Buy	2,255 +587	+35%	+$59.6K	﹤0.01%	890
2014 Q4	$148K	Buy	1,668 +1,042	+166%	+$98.6K	﹤0.01%	909
2014 Q3	$60.7K	Buy	+626	New	+$60.9K	﹤0.01%	923